Silvano Capitani

Via Fossato Di Mortara, 70
Ferrara, 44121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Correction: Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.

Correction: Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling.

Journal: Oncotarget

Published: August 14, 2026

Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA).

Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA).

Journal: Stem cell reviews and reports

Published: October 27, 2020

CD133 in Breast Cancer Cells: More than a Stem Cell Marker.

CD133 in Breast Cancer Cells: More than a Stem Cell Marker.

Journal: Journal of oncology

Published: April 26, 2019

Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.

Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a.

Journal: Molecular carcinogenesis

Published: October 31, 2018

Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells.

Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells.

Journal: BMC cancer

Published: June 18, 2018

Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.

Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.

Journal: Journal of cellular physiology

Published: March 18, 2018

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.

Vav1 downmodulates Akt in different breast cancer subtypes: a new promising chance to improve breast cancer outcome.

Journal: Molecular oncology

Published: February 23, 2018

Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.

Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.

Journal: Oncotarget

Published: December 26, 2017

Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases.

Influence of physical exercise on microRNAs in skeletal muscle regeneration, aging and diseases.

Journal: Oncotarget

Published: December 21, 2017

Impact of physical exercise in cancer survivors during and after antineoplastic treatments.

Impact of physical exercise in cancer survivors during and after antineoplastic treatments.

Journal: Oncotarget

Published: December 17, 2017

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.

Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells.

Journal: Oncotarget

Published: November 28, 2017

Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update.

Targeting the phosphatidylinositol 3-kinase/Akt/mechanistic target of rapamycin signaling pathway in B-lineage acute lymphoblastic leukemia: An update.

Journal: Journal of cellular physiology

Published: November 09, 2017

Showing 1-12 of 34

Last Updated: 09/26/2026